Akin Advises Pharmakon in its Up to $500 Million Debt Facility Financing for Valneva SE
Contact:
(New York and Washington, D.C.) – Akin advised Pharmakon Advisors, LP and its affiliated funds in providing Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, with a debt facility for up to $500 million in non-dilutive financing. The initial tranche of $215 million will be used to repay in full the Company’s existing debt facility with Deerfield Management Company and OrbiMed, inclusive of associated fees and expenses, and is expected to be funded in the coming weeks.
The Akin team was led by tax partner Geoffrey Secol and included fellow tax partners Stuart Leblang and David Snyder; corporate associates Jake Gawlak and Casey Braden; and tax associate John Kwack. Additional support was provided by international trade partner Nnedinma Ifudu Nweke and health care & life sciences partner Nate Brown, senior counsel Jo-Ellyn Klein and counsel Caroline Kessler.
For additional information on the transaction, please click here.
Akin is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.
# # #
People Mentioned in This News
